التفاصيل البيبلوغرافية
| العنوان: |
Comment on "PP2A inhibition sensitizes cancer stem cells to ABL tyrosine kinase inhibitors in BCR-ABL human leukemia". |
| المؤلفون: |
Perrotti, Danilo, Agarwal, Anupriya, Lucas, Claire M., Narla, Goutham, Neviani, Paolo, Odero, Maria D., Ruvolo, Peter P., Verrills, Nicole M. |
| المصدر: |
Science Translational Medicine; 7/17/2019, Vol. 11 Issue 501, p1-3, 3p |
| مصطلحات موضوعية: |
CANCER stem cells, PROTEIN-tyrosine kinases, KINASE inhibitors, LEUKEMIA, STEM cells |
| مستخلص: |
LB100 does not sensitize CML stem cells to tyrosine kinase inhibitor–induced apoptosis. [ABSTRACT FROM AUTHOR] |
|
Copyright of Science Translational Medicine is the property of American Association for the Advancement of Science and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
